作为潜在的抗病毒和抗癌剂的新型佐-亚基子:合成,DFT和分子对接研究
Khadra B Alomari1, Abdulmajeed F Alrefaei2, Renad Almughathawi3
1Jazan University, Department of Physical Sciences, Chemistry Division, Jazan, Kingdom of Saudi Arabia.
Chemical biology & drug design
|February 24, 2025
概括
新的本佐提亚-提亚基显示出有前途的抗增殖和抗病毒活性. DFT研究和分子对接揭示了关键相互作用,有可能开发抗癌和H5N1流感的药物.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 计算化学计算化学
背景情况:
- 佐醇和亚醇支架在生物活性化合物中普遍存在.
- 开发具有抗增殖和抗病毒特性的新药非常重要.
研究的目的:
- 合成和表征新的基因基因基因基因基因基因基因基因基因.
- 评估它们的抗增殖和H5N1抗病毒活动.
- 使用计算方法调查结构-活动关系.
主要方法:
- 化学合成和表征 (IR,NMR,MS) 的方法.
- 密度函数理论 (DFT) 用于电子结构分析.
- 针对癌细胞系的体外抗增殖试验.
- 减少H5N1斑块的测试和毒性测试.
- 分子对接和瑞士ADME分析.
主要成果:
- 成功合成了基4a-i和6a-c.
- DFT研究揭示了电子性质,其中基衍生物显示出扩展的HOMO.
- 基4a,4i和6a对MCF-7,HepG2和Panc-1细胞分别表现出显著的抗增殖活性.
- 子2a,4e和4g实现了100%的H5N1抑制,4e显示低毒性.
- 分子对接表明4e与目标残留物具有强烈的结合亲和力.
结论:
- 合成的佐-亚基具有显著的抗增殖和抗病毒潜力.
- 计算研究为它们的作用机制提供了宝贵的见解,并指导进一步的优化.
- 这些化合物代表了开发新治疗剂的有希望的线索.
相关概念视频
Antihypertensive Drugs: Thiazide-Class Diuretics
517
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
517
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
212
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
212
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Electron Transport Chain: Complex I and II
10.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.2K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
172
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
172


